R Brett McQueen

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

PharmacoEconomics

PharmacoEconomics - open

American journal of cardiovascular drugs : drugs, devices, and other interventions

Applied health economics and health policy

University of Colorado

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Colorado Oct 01 2016

United States

Assistant Professor :: Pharmacy

Publications

R Brett McQueen, Kelly E Anderson, Joseph F Levy, Josh J Carlson
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? PharmacoEconomics (2023)
R Brett McQueen, Kelly E Anderson, Joseph F Levy, Josh J Carlson
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? PharmacoEconomics 41 (3) (2023)
R Brett McQueen, Kelly E Anderson, Joseph F Levy, Josh J Carlson
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? PharmacoEconomics 41 (3) (2023)
R Brett McQueen, Kelly E Anderson, Joseph F Levy, Josh J Carlson
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? PharmacoEconomics 41 (3) (2023)
R Brett McQueen, Kelly E Anderson, Joseph F Levy, Josh J Carlson
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? PharmacoEconomics 41 (3) (2023)
R Brett McQueen, Nicholas D Mendola, Ivett Jakab, Jeffrey Bennett, Kavita V Nair, Bertalan Németh, András Inotai, Zoltán Kaló
Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods. PharmacoEconomics - open (2022)
R Brett McQueen, Seth J Baum, Michael J Louie, William J Sasiela, Aikaterini Bilitou, Hemal Shah, Beth Nash, Kristin K Gillard, Kausik K Ray
Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins. American journal of cardiovascular drugs : drugs, devices, and other interventions (2022)
R Brett McQueen, Julia F Slejko
Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment. PharmacoEconomics 39 (4) (2021)
Taryn A G Quinlan, Brock Schroeder, Sue Kwon, Jane F Barlow, Michael S Sherman, Heather D Anderson, Garth Wright, R Brett McQueen
Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement. PharmacoEconomics - open 5 (3) (2021)
Joseph T Mattingly, R Brett McQueen, Pei-Jung Lin
Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease Therapies. PharmacoEconomics 39 (10) (2021)
Wei Gao, Dominic Muston, Matthew Monberg, Kimmie McLaurin, Robert Hettle, Elizabeth Szamreta, Elyse Swallow, Su Zhang, Iden Kalemaj, James Signorovitch, R Brett McQueen
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer. PharmacoEconomics 38 (11) (2021)
R Brett McQueen, Cristy Geno Rasmussen, Kathleen Waugh, Brigitte I Frohnert, Andrea K Steck, Liping Yu, Judith Baxter, Marian Rewers
Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado. Diabetes care 43 (7) (2020)
R Brett McQueen
What Value Does the NCCN Affordability Rating Really Provide to Patients, Providers, and Society? PharmacoEconomics 38 (7) (2020)
William V Padula, R Brett McQueen
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments. Applied health economics and health policy 17 (6) (2020)
R Brett McQueen, Melanie D Whittington, Rick H Chapman, Varun M Kumar, Jonathan D Campbell
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States". PharmacoEconomics 37 (7) (2019)

R Brett McQueen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

R Brett McQueen